A Phase II Trial of Stanford VI ± Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease With 3+ Risk Factors: the G6 Study

Trial Profile

A Phase II Trial of Stanford VI ± Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease With 3+ Risk Factors: the G6 Study

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2014

At a glance

  • Drugs Gemcitabine (Primary) ; Vinorelbine (Primary) ; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Vinblastine; Vincristine
  • Indications Hodgkin's disease
  • Focus Therapeutic Use
  • Acronyms G6 Study
  • Most Recent Events

    • 30 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top